Showing 3811-3820 of 8791 results for "".
New and Next in MIGS
https://crstoday.com/crst-supplements/an-inside-look-at-innovations-in-ophthalmology-april-2023/new-and-next-in-migs/44977/Groovin’ for Safer Phacoemulsification
https://crstoday.com/crst-issues/jan-2023/groovin-for-safer-phacoemulsification/44911/Dr. LaBorwit explains how his technique for making the groove creates an opportunity for safer phacoemulsification.Dry Eye Management Done Right
https://crstoday.com/crst-issues/nov-dec-2021/dry-eye-management-done-right/44604/An understanding of risk factors is required.Optimizing Outcomes When the Target Is Low Myopia
https://crstoday.com/topics/cataract-surgery/optimizing-outcomes-when-the-target-is-low-myopia/44398/Different IOL calculation methods may be required for the near-vision eye when monovision strategies are employed.Increasing Premium IOL Adoption After the Pandemic
https://crstoday.com/topics/cataract-surgery/increasing-premium-iol-adoption-after-the-pandemic/44279/Who is driving these discussions in your practice?Advantages of an Office-Based Surgery Center in the Current Climate
https://crstoday.com/crst-issues/2020-june/advantages-of-an-office-based-surgery-center-in-the-current-climate/44261/These facilities can offer improved safety and familiarity for patients.Strategies That Can Bring in New Business
https://crstoday.com/crst-issues/2019-feb/strategies-that-can-bring-in-new-business/43904/Focusing on these three areas can help attract new patients.Your Hidden Gold Mine
https://crstoday.com/topics/practice-management/your-hidden-gold-mine/43755/The data your practice is missing are at your fingertips; you just need the right tools to mine this treasure and, in return, enhance workflow efficiency.How to Present RLE to Patients in Three Simple Steps
https://crstoday.com/topics/refractive-surgery/best-practices-in-integrated-care/43387/Take the challenge out of discussing dysfunctional lens syndrome.More Than Enough to Go Around
https://crstoday.com/topics/general/more-than-enough-to-go-around/43319/Pharma executive says the outlook for the dry eye disease market is bright.